Literature DB >> 24687630

Pathophysiology of glia in perinatal white matter injury.

Stephen A Back1, Paul A Rosenberg.   

Abstract

Injury to the preterm brain has a particular predilection for cerebral white matter. White matter injury (WMI) is the most common cause of brain injury in preterm infants and a major cause of chronic neurological morbidity including cerebral palsy. Factors that predispose to WMI include cerebral oxygenation disturbances and maternal-fetal infection. During the acute phase of WMI, pronounced oxidative damage occurs that targets late oligodendrocyte progenitors (pre-OLs). The developmental predilection for WMI to occur during prematurity appears to be related to both the timing of appearance and regional distribution of susceptible pre-OLs that are vulnerable to a variety of chemical mediators including reactive oxygen species, glutamate, cytokines, and adenosine. During the chronic phase of WMI, the white matter displays abberant regeneration and repair responses. Early OL progenitors respond to WMI with a rapid robust proliferative response that results in a several fold regeneration of pre-OLs that fail to terminally differentiate along their normal developmental time course. Pre-OL maturation arrest appears to be related in part to inhibitory factors that derive from reactive astrocytes in chronic lesions. Recent high field magnetic resonance imaging (MRI) data support that three distinct forms of chronic WMI exist, each of which displays unique MRI and histopathological features. These findings suggest the possibility that therapies directed at myelin regeneration and repair could be initiated early after WMI and monitored over time. These new mechanisms of acute and chronic WMI provide access to a variety of new strategies to prevent or promote repair of WMI in premature infants.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  hyperoxia; hypoxia; hypoxia-ischemia; myelin; oligodendrocyte

Mesh:

Substances:

Year:  2014        PMID: 24687630      PMCID: PMC4163108          DOI: 10.1002/glia.22658

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  338 in total

1.  Voltage-activated K+ channels and membrane depolarization regulate accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in glial progenitor cells.

Authors:  C A Ghiani; X Yuan; A M Eisen; P L Knutson; R A DePinho; C J McBain; V Gallo
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

2.  Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination.

Authors:  Ben Emery; Dritan Agalliu; John D Cahoy; Trent A Watkins; Jason C Dugas; Sara B Mulinyawe; Adilijan Ibrahim; Keith L Ligon; David H Rowitch; Ben A Barres
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

3.  Chronic conditions, functional limitations, and special health care needs of school-aged children born with extremely low-birth-weight in the 1990s.

Authors:  Maureen Hack; H Gerry Taylor; Dennis Drotar; Mark Schluchter; Lydia Cartar; Laura Andreias; Deanne Wilson-Costello; Nancy Klein
Journal:  JAMA       Date:  2005-07-20       Impact factor: 56.272

4.  Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists.

Authors:  E Bona; U Adén; E Gilland; B B Fredholm; H Hagberg
Journal:  Neuropharmacology       Date:  1997-09       Impact factor: 5.250

Review 5.  The role of hypoxia-inducible transcription factors in the hypoxic neonatal brain.

Authors:  Regina Trollmann; Max Gassmann
Journal:  Brain Dev       Date:  2009-04-26       Impact factor: 1.961

Review 6.  Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis.

Authors:  P W Fowlie; P G Davis
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-11       Impact factor: 5.747

7.  Quality of general movements is related to white matter pathology in very preterm infants.

Authors:  Alicia J Spittle; Nisha C Brown; Lex W Doyle; Roslyn N Boyd; Rod W Hunt; Merilyn Bear; Terrie E Inder
Journal:  Pediatrics       Date:  2008-04-07       Impact factor: 7.124

8.  Neural stem/progenitor cells participate in the regenerative response to perinatal hypoxia/ischemia.

Authors:  Ryan J Felling; Matthew J Snyder; Michael J Romanko; Raymond P Rothstein; Amber N Ziegler; Zhengang Yang; Maria I Givogri; Ernesto R Bongarzone; Steven W Levison
Journal:  J Neurosci       Date:  2006-04-19       Impact factor: 6.167

9.  Hemodynamic and metabolic correlates of perinatal white matter injury severity.

Authors:  Art Riddle; Jennifer Maire; Victor Cai; Thuan Nguyen; Xi Gong; Kelly Hansen; Marjorie R Grafe; A Roger Hohimer; Stephen A Back
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

10.  Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models.

Authors:  N Takahashi; L Duprez; S Grootjans; A Cauwels; W Nerinckx; J B DuHadaway; V Goossens; R Roelandt; F Van Hauwermeiren; C Libert; W Declercq; N Callewaert; G C Prendergast; A Degterev; J Yuan; P Vandenabeele
Journal:  Cell Death Dis       Date:  2012-11-29       Impact factor: 8.469

View more
  82 in total

Review 1.  Controversies in preterm brain injury.

Authors:  Anna A Penn; Pierre Gressens; Bobbi Fleiss; Stephen A Back; Vittorio Gallo
Journal:  Neurobiol Dis       Date:  2015-10-23       Impact factor: 5.996

Review 2.  Developmental neurotoxicity of inhaled ambient ultrafine particle air pollution: Parallels with neuropathological and behavioral features of autism and other neurodevelopmental disorders.

Authors:  J L Allen; G Oberdorster; K Morris-Schaffer; C Wong; C Klocke; M Sobolewski; K Conrad; M Mayer-Proschel; D A Cory-Slechta
Journal:  Neurotoxicology       Date:  2015-12-22       Impact factor: 4.294

3.  Diazoxide promotes oligodendrocyte differentiation in neonatal brain in normoxia and chronic sublethal hypoxia.

Authors:  Ying Zhu; Christopher C Wendler; Olivia Shi; Scott A Rivkees
Journal:  Brain Res       Date:  2014-08-23       Impact factor: 3.252

4.  Attenuating Ischemic Disruption of K+ Homeostasis in the Cortex of Hypoxic-Ischemic Neonatal Rats: DOR Activation vs. Acupuncture Treatment.

Authors:  Dongman Chao; Qinyu Wang; Gianfranco Balboni; Guanghong Ding; Ying Xia
Journal:  Mol Neurobiol       Date:  2015-12-19       Impact factor: 5.590

5.  Transient Hypoxemia Chronically Disrupts Maturation of Preterm Fetal Ovine Subplate Neuron Arborization and Activity.

Authors:  Evelyn McClendon; Daniel C Shaver; Kiera Degener-O'Brien; Xi Gong; Thuan Nguyen; Anna Hoerder-Suabedissen; Zoltán Molnár; Claudia Mohr; Ben D Richardson; David J Rossi; Stephen A Back
Journal:  J Neurosci       Date:  2017-10-31       Impact factor: 6.167

Review 6.  Congenital cardiac anomalies and white matter injury.

Authors:  Paul D Morton; Nobuyuki Ishibashi; Richard A Jonas; Vittorio Gallo
Journal:  Trends Neurosci       Date:  2015-05-01       Impact factor: 13.837

7.  Enhancing Oligodendrocyte Myelination Rescues Synaptic Loss and Improves Functional Recovery after Chronic Hypoxia.

Authors:  Fei Wang; Yu-Jian Yang; Nian Yang; Xian-Jun Chen; Nan-Xin Huang; Jun Zhang; Yi Wu; Zhi Liu; Xing Gao; Tao Li; Guang-Qiang Pan; Shu-Bao Liu; Hong-Li Li; Stephen P J Fancy; Lan Xiao; Jonah R Chan; Feng Mei
Journal:  Neuron       Date:  2018-08-02       Impact factor: 17.173

Review 8.  Dysregulation of Hyaluronan Homeostasis During White Matter Injury.

Authors:  Taasin Srivastava; Larry S Sherman; Stephen A Back
Journal:  Neurochem Res       Date:  2019-09-21       Impact factor: 3.996

Review 9.  Intracellular signaling pathway regulation of myelination and remyelination in the CNS.

Authors:  Jenna M Gaesser; Sharyl L Fyffe-Maricich
Journal:  Exp Neurol       Date:  2016-03-05       Impact factor: 5.330

Review 10.  Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Rémy Guillevin; Yves Lecarpentier
Journal:  Cell Mol Neurobiol       Date:  2017-09-13       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.